Professor of Pharmacology and Director of the Institute of Pharmacology of the University of Bern (Switzerland)
Hans-Uwe Simon is one of the leading international scientists in the field of the molecular mechanisms of inflammation, cell death, and carcinogenesis. His work in the domain of hypereosinophilic syndromes laid the foundations for a new classification of these conditions. Apart from that, with the direct participation of the researcher's group, an anti-eosinophilic drug, mepolizumab, was developed and registered as a medication. The drug is the first in its class. Among other achievements of Prof. Simon are the development of a new corticosteroid therapy method for eosinophilic esophagitis that is currently the main approach to the treatment of this disease.
Hosting organization
|
Field of studies
|
City
|
Invited researcher
|
Time span of the project
|
---|---|---|---|---|
Functional Quantum Materials Laboratory
National University of Science and Technology MISIS - (NUST MISIS) |
Physics |
Moscow |
Klingeler Rudiger |
2021-2023 |
Laboratory of the Spin Physics of Two-Dimensional Materials
Р.N. Lebedev Physical Institute of the RAS - (LPI) |
Physics |
Moscow |
Yakovlev Dmitriy Robertovich
Russia |
2021-2023 |
Laboratory for Microwave Photonics and Magnonics named after B. A. Kalinikos
Saint Petersburg Electrotechnical University «LETI» - (ETU LETI) |
Physics |
St. Petersburg |
Kostylev Mikhail Pavlovich
Australia, Russia |
2021-2023 |